Zymeworks (ZYME) Intangibles (2021 - 2026)
Zymeworks recorded quarterly Intangibles of $1.2 million in Q1 2026, down 13.04% quarter-over-quarter from $1.3 million in Q4 2025, and down 65.08% year-over-year from $3.4 million in Q1 2025.
Zymeworks' Intangibles history runs 6 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Intangibles fell 65.08% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.2 million (down 65.08% YoY), while the FY2025 annual figure was $1.3 million, down 70.5% from the prior year.
- Intangibles came in at $1.2 million for Q1 2026 at Zymeworks, down from $1.3 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $17.6 million in Q4 2022 to a low of $341000.0 in Q2 2024.
- A 5-year average of $7.8 million and a median of $6.4 million in 2024 frame the typical range for Intangibles.
- Across the five-year window, Intangibles tumbled 98.07% in 2024 and soared 499.71% in 2025, its largest moves.
- Zymeworks' Intangibles stood at $17.6 million in 2022, then changed by 0.0% to $17.6 million in 2023, then sank by 74.04% to $4.6 million in 2024, then tumbled by 70.5% to $1.3 million in 2025, then dropped by 13.04% to $1.2 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $1.2 million, $1.3 million, and $1.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 4.41 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 11,640.44 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 30.30 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 418.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.29 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - | 1.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.17 Mn |
| Dec 31, 2025 | 1.35 Mn |
| Sep 30, 2025 | 1.40 Mn |
| Jun 30, 2025 | 2.05 Mn |
| Mar 31, 2025 | 3.36 Mn |
| Dec 31, 2024 | 4.58 Mn |
| Sep 30, 2024 | 6.41 Mn |
| Jun 30, 2024 | 341,000.00 |
| Mar 31, 2024 | 17.63 Mn |
| Dec 31, 2023 | 17.63 Mn |
| Sep 30, 2023 | 8.00 Mn |
| Jun 30, 2023 | 17.63 Mn |
| Mar 31, 2023 | 8.08 Mn |
| Dec 31, 2022 | 17.63 Mn |
| Sep 30, 2022 | 9.02 Mn |
| Dec 31, 2021 | 17.63 Mn |